Geojunxion_RGB.png
GeoJunxion NV (ticker: GOJXN.AS) - Financiële en Operationele update Q1 FY 2023-24 (juli – september 2023)
16 nov. 2023 02h00 HE | GeoJunxion N.V.
Capelle aan den IJssel, 16 november 2023, GeoJunxion kondigt de publicatie aan van de financiële resultaten voor de eerste drie maanden van het boekjaar 2023-24, waaruit de eerste tekenen blijken van...
Geojunxion_RGB.png
GeoJunxion NV (ticker: GOJXN.AS) - Financial & Business update Q1 FY 2023-24 (July – September 2023)
16 nov. 2023 02h00 HE | GeoJunxion N.V.
Capelle aan den IJssel, 16 November 2023, GeoJunxion announces the publication of its financial results for the first three months of the accounting year 2023-24, showing first evidence of slowdown in...
SeaStar_SM_LogoCard.png
SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business Update
14 nov. 2023 16h04 HE | SeaStar Medical Holding Corporation
DENVER, Nov. 14, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (“SeaStar Medical” or the “Company”), a medical device company developing proprietary solutions to reduce...
Logo.png
IMUNON Reports Third Quarter 2023 Financial Results and Provides a Business Update
14 nov. 2023 08h00 HE | Imunon, Inc.
Advances Non-Viral DNA-Mediated Cancer Immunotherapy and Next-Generation Vaccine Programs, with More Potent and Durable Immunity, with Multiple Near-Term Milestones Conference Call Begins...
Celyad-Logo-Color.jpg
Celyad Oncology reports third quarter 2023 financial results and recent business highlights
09 nov. 2023 01h00 HE | Celyad Oncology SA
Publication of data detailing the development of our microRNA (miRNA)-based multiplex shRNA approach, which allows to down-regulate several genes simultaneously, in Molecular Therapy – Nucleic...
Logo.png
IMUNON to Hold Third Quarter 2023 Financial Results and Business Update Conference Call on Tuesday, November 14, 2023
07 nov. 2023 08h30 HE | Imunon, Inc.
LAWRENCEVILLE, N.J., Nov. 07, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing DNA-mediated immunotherapy and next-generation...
Picture1.png
Coffee Holdings Co., Inc. Issues Business Update Following 2023 Annual Meeting
03 nov. 2023 08h00 HE | Coffee Holding Co., Inc.
STATEN ISLAND, New York, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Coffee Holding Co., Inc. (Nasdaq: JVA) (the “Company”) today provided a business update following its 2023 Annual Meeting held on October...
ONWARD_Logotype®_Red.png
ONWARD Schedules Webcast to Provide Third Quarter 2023 Business Update
11 oct. 2023 13h43 HE | ONWARD Medical NV
Eindhoven, Netherlands, Oct. 11, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function, and...
DHT_logo.jpg
DHT Holdings, Inc. Business Update
10 oct. 2023 16h15 HE | DHT Holdings, Inc.
 HAMILTON, BERMUDA, October 10, 2023 – DHT Holdings, Inc. (NYSE:DHT) (“DHT” or the “Company”) today provides the following business update:  For the third quarter of 2023, the Company...
ONWARD_Logotype®_Red.png
ONWARD® comunica la relazione finanziaria semestrale 2023 e provvede un aggiornamento aziendale
19 sept. 2023 00h30 HE | ONWARD Medical
Eindhoven, Sept. 19, 2023 (GLOBE NEWSWIRE) -- IL PRESENTE COMUNICATO STAMPA CONTIENE INFORMAZIONI PRIVILEGIATE AI SENSI DELL'ARTICOLO 7, PARAGRAFO 1, DEL REGOLAMENTO EUROPEO SUGLI ABUSI DI MERCATO...